Novo Nordisk: Don't Ignore This Dirt-Cheap Buying Opportunity (NYSE:NVO)
· seekingalpha.com
Novo Nordisk (NVO) may be bottoming as LLY share losses stabilize; trading ~15x forward earnings with catalysts like Wegovy pill & CagriSema.
Novo Nordisk ( NVO ) investors are finally ready to rip off the band-aid as the stock is looking ready to turn around as the stock has arguably
JR Research is ...